ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing

Abstract Background Identifying nuclease-induced double-stranded breaks in DNA on a genome-wide scale is critical for assessing the safety and efficacy of genome editing therapies. We previously demonstrated that after administering adeno-associated viral (AAV) vector-mediated genome-editing strateg...

Full description

Bibliographic Details
Main Authors: Camilo Breton, Peter M. Clark, Lili Wang, Jenny A. Greig, James M. Wilson
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12864-020-6655-4
_version_ 1819060130091630592
author Camilo Breton
Peter M. Clark
Lili Wang
Jenny A. Greig
James M. Wilson
author_facet Camilo Breton
Peter M. Clark
Lili Wang
Jenny A. Greig
James M. Wilson
author_sort Camilo Breton
collection DOAJ
description Abstract Background Identifying nuclease-induced double-stranded breaks in DNA on a genome-wide scale is critical for assessing the safety and efficacy of genome editing therapies. We previously demonstrated that after administering adeno-associated viral (AAV) vector-mediated genome-editing strategies in vivo, vector sequences integrated into the host organism’s genomic DNA at double-stranded breaks. Thus, identifying the genomic location of inserted AAV sequences would enable us to identify DSB events, mainly derived from the nuclease on- and off-target activity. Results Here, we developed a next-generation sequencing assay that detects insertions of specific AAV vector sequences called inverted terminal repeats (ITRs). This assay, ITR-Seq, enables us to identify off-target nuclease activity in vivo. Using ITR-Seq, we analyzed liver DNA samples of rhesus macaques treated with AAV vectors expressing a meganuclease. We found dose-dependent off-target activity and reductions in off-target events induced by further meganuclease development. In mice, we identified the genomic locations of ITR integration after treatment with Cas9 nucleases and their corresponding single-guide RNAs. Conclusions In sum, ITR-Seq is a powerful method for identifying off-target sequences induced by AAV vector-delivered genome-editing nucleases. ITR-Seq will help us understand the specificity and efficacy of different genome-editing nucleases in animal models and clinical studies. This information can help enhance the safety profile of gene-editing therapies.
first_indexed 2024-12-21T14:22:06Z
format Article
id doaj.art-84dd2ff60759418d8a28d6e3f281d5ef
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-12-21T14:22:06Z
publishDate 2020-03-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-84dd2ff60759418d8a28d6e3f281d5ef2022-12-21T19:00:45ZengBMCBMC Genomics1471-21642020-03-0121111210.1186/s12864-020-6655-4ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editingCamilo Breton0Peter M. Clark1Lili Wang2Jenny A. Greig3James M. Wilson4Gene Therapy Program, University of Pennsylvania Perelman School of MedicineGene Therapy Program, University of Pennsylvania Perelman School of MedicineGene Therapy Program, University of Pennsylvania Perelman School of MedicineGene Therapy Program, University of Pennsylvania Perelman School of MedicineGene Therapy Program, University of Pennsylvania Perelman School of MedicineAbstract Background Identifying nuclease-induced double-stranded breaks in DNA on a genome-wide scale is critical for assessing the safety and efficacy of genome editing therapies. We previously demonstrated that after administering adeno-associated viral (AAV) vector-mediated genome-editing strategies in vivo, vector sequences integrated into the host organism’s genomic DNA at double-stranded breaks. Thus, identifying the genomic location of inserted AAV sequences would enable us to identify DSB events, mainly derived from the nuclease on- and off-target activity. Results Here, we developed a next-generation sequencing assay that detects insertions of specific AAV vector sequences called inverted terminal repeats (ITRs). This assay, ITR-Seq, enables us to identify off-target nuclease activity in vivo. Using ITR-Seq, we analyzed liver DNA samples of rhesus macaques treated with AAV vectors expressing a meganuclease. We found dose-dependent off-target activity and reductions in off-target events induced by further meganuclease development. In mice, we identified the genomic locations of ITR integration after treatment with Cas9 nucleases and their corresponding single-guide RNAs. Conclusions In sum, ITR-Seq is a powerful method for identifying off-target sequences induced by AAV vector-delivered genome-editing nucleases. ITR-Seq will help us understand the specificity and efficacy of different genome-editing nucleases in animal models and clinical studies. This information can help enhance the safety profile of gene-editing therapies.http://link.springer.com/article/10.1186/s12864-020-6655-4Genome editingOff-targetsNext-generation sequencingIn vivoEditingAAV integration
spellingShingle Camilo Breton
Peter M. Clark
Lili Wang
Jenny A. Greig
James M. Wilson
ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
BMC Genomics
Genome editing
Off-targets
Next-generation sequencing
In vivo
Editing
AAV integration
title ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
title_full ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
title_fullStr ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
title_full_unstemmed ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
title_short ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
title_sort itr seq a next generation sequencing assay identifies genome wide dna editing sites in vivo following adeno associated viral vector mediated genome editing
topic Genome editing
Off-targets
Next-generation sequencing
In vivo
Editing
AAV integration
url http://link.springer.com/article/10.1186/s12864-020-6655-4
work_keys_str_mv AT camilobreton itrseqanextgenerationsequencingassayidentifiesgenomewidednaeditingsitesinvivofollowingadenoassociatedviralvectormediatedgenomeediting
AT petermclark itrseqanextgenerationsequencingassayidentifiesgenomewidednaeditingsitesinvivofollowingadenoassociatedviralvectormediatedgenomeediting
AT liliwang itrseqanextgenerationsequencingassayidentifiesgenomewidednaeditingsitesinvivofollowingadenoassociatedviralvectormediatedgenomeediting
AT jennyagreig itrseqanextgenerationsequencingassayidentifiesgenomewidednaeditingsitesinvivofollowingadenoassociatedviralvectormediatedgenomeediting
AT jamesmwilson itrseqanextgenerationsequencingassayidentifiesgenomewidednaeditingsitesinvivofollowingadenoassociatedviralvectormediatedgenomeediting